nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP2C18—prostate cancer	0.11	0.333	CbGaD
Omeprazole—CYP1B1—prostate cancer	0.0908	0.275	CbGaD
Omeprazole—CYP2C19—prostate cancer	0.0492	0.149	CbGaD
Omeprazole—CYP1A1—prostate cancer	0.049	0.149	CbGaD
Omeprazole—CYP1B1—Flutamide—prostate cancer	0.0346	0.0805	CbGbCtD
Omeprazole—CYP3A4—prostate cancer	0.0313	0.0948	CbGaD
Omeprazole—CYP1B1—Estrone—prostate cancer	0.025	0.0582	CbGbCtD
Omeprazole—ABCC3—Conjugated Estrogens—prostate cancer	0.0189	0.0441	CbGbCtD
Omeprazole—CYP1A1—Flutamide—prostate cancer	0.0152	0.0353	CbGbCtD
Omeprazole—CYP1B1—Mitoxantrone—prostate cancer	0.0149	0.0346	CbGbCtD
Omeprazole—CYP1B1—Estradiol—prostate cancer	0.0144	0.0334	CbGbCtD
Omeprazole—ABCG2—Cabazitaxel—prostate cancer	0.0122	0.0283	CbGbCtD
Omeprazole—ABCG2—Estrone—prostate cancer	0.0119	0.0277	CbGbCtD
Omeprazole—CYP1A1—Estrone—prostate cancer	0.011	0.0255	CbGbCtD
Omeprazole—ABCC3—Etoposide—prostate cancer	0.0109	0.0253	CbGbCtD
Omeprazole—CYP2C8—Nilutamide—prostate cancer	0.0106	0.0246	CbGbCtD
Omeprazole—CYP2C19—Bicalutamide—prostate cancer	0.00887	0.0206	CbGbCtD
Omeprazole—CYP2C19—Nilutamide—prostate cancer	0.00887	0.0206	CbGbCtD
Omeprazole—CYP2C8—Abiraterone—prostate cancer	0.00876	0.0204	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—prostate cancer	0.00859	0.02	CbGbCtD
Omeprazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00817	0.019	CbGbCtD
Omeprazole—ABCG2—Conjugated Estrogens—prostate cancer	0.00778	0.0181	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—prostate cancer	0.0074	0.0172	CbGbCtD
Omeprazole—CYP2C9—Nilutamide—prostate cancer	0.00738	0.0172	CbGbCtD
Omeprazole—CYP2C9—Bicalutamide—prostate cancer	0.00738	0.0172	CbGbCtD
Omeprazole—CYP2C19—Flutamide—prostate cancer	0.00735	0.0171	CbGbCtD
Omeprazole—ABCG2—Mitoxantrone—prostate cancer	0.00707	0.0165	CbGbCtD
Omeprazole—ABCG2—Estradiol—prostate cancer	0.00683	0.0159	CbGbCtD
Omeprazole—CYP1A2—Flutamide—prostate cancer	0.00678	0.0158	CbGbCtD
Omeprazole—CYP2D6—Bicalutamide—prostate cancer	0.00675	0.0157	CbGbCtD
Omeprazole—ABCB1—Estramustine—prostate cancer	0.00666	0.0155	CbGbCtD
Omeprazole—CYP2C8—Cabazitaxel—prostate cancer	0.00648	0.0151	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—prostate cancer	0.0064	0.0149	CbGbCtD
Omeprazole—CYP1A1—Estradiol—prostate cancer	0.00631	0.0147	CbGbCtD
Omeprazole—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00565	0.0131	CbGbCtD
Omeprazole—CYP2D6—Abiraterone—prostate cancer	0.00559	0.013	CbGbCtD
Omeprazole—CYP1A2—Estrone—prostate cancer	0.0049	0.0114	CbGbCtD
Omeprazole—ABCG2—Etoposide—prostate cancer	0.00446	0.0104	CbGbCtD
Omeprazole—CYP2C9—Estrone—prostate cancer	0.00442	0.0103	CbGbCtD
Omeprazole—ABCB1—Cabazitaxel—prostate cancer	0.00439	0.0102	CbGbCtD
Omeprazole—CYP3A4—Bicalutamide—prostate cancer	0.00429	0.00998	CbGbCtD
Omeprazole—ABCB1—Estrone—prostate cancer	0.00429	0.00998	CbGbCtD
Omeprazole—ABCG2—Docetaxel—prostate cancer	0.00408	0.00949	CbGbCtD
Omeprazole—CYP3A4—Estramustine—prostate cancer	0.00399	0.00928	CbGbCtD
Omeprazole—ABCB1—Ethinyl Estradiol—prostate cancer	0.00382	0.00889	CbGbCtD
Omeprazole—CYP2C8—Estradiol—prostate cancer	0.00364	0.00847	CbGbCtD
Omeprazole—CYP3A4—Abiraterone—prostate cancer	0.00355	0.00827	CbGbCtD
Omeprazole—CYP3A4—Flutamide—prostate cancer	0.00355	0.00827	CbGbCtD
Omeprazole—CYP2C9—Capecitabine—prostate cancer	0.00335	0.00779	CbGbCtD
Omeprazole—CYP1A2—Conjugated Estrogens—prostate cancer	0.00321	0.00746	CbGbCtD
Omeprazole—CYP2C19—Estradiol—prostate cancer	0.00305	0.0071	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—prostate cancer	0.00304	0.00708	CbGbCtD
Omeprazole—CYP1A2—Estradiol—prostate cancer	0.00282	0.00655	CbGbCtD
Omeprazole—ABCB1—Conjugated Estrogens—prostate cancer	0.00281	0.00653	CbGbCtD
Omeprazole—CYP3A4—Cabazitaxel—prostate cancer	0.00263	0.00612	CbGbCtD
Omeprazole—CYP2C19—Prednisone—prostate cancer	0.00263	0.00611	CbGbCtD
Omeprazole—CYP3A4—Estrone—prostate cancer	0.00257	0.00598	CbGbCtD
Omeprazole—ABCB1—Mitoxantrone—prostate cancer	0.00255	0.00593	CbGbCtD
Omeprazole—CYP2C9—Estradiol—prostate cancer	0.00254	0.0059	CbGbCtD
Omeprazole—ABCB1—Estradiol—prostate cancer	0.00246	0.00573	CbGbCtD
Omeprazole—CYP2C8—Etoposide—prostate cancer	0.00238	0.00553	CbGbCtD
Omeprazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00229	0.00533	CbGbCtD
Omeprazole—ABCB1—Prednisone—prostate cancer	0.00212	0.00493	CbGbCtD
Omeprazole—CYP1A2—Etoposide—prostate cancer	0.00184	0.00428	CbGbCtD
Omeprazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00168	0.00391	CbGbCtD
Omeprazole—ABCB1—Etoposide—prostate cancer	0.00161	0.00374	CbGbCtD
Omeprazole—CYP3A4—Mitoxantrone—prostate cancer	0.00153	0.00355	CbGbCtD
Omeprazole—CYP3A4—Estradiol—prostate cancer	0.00148	0.00343	CbGbCtD
Omeprazole—ABCB1—Docetaxel—prostate cancer	0.00147	0.00342	CbGbCtD
Omeprazole—CYP2C19—urine—prostate cancer	0.00141	0.0832	CbGeAlD
Omeprazole—CYP3A4—Prednisone—prostate cancer	0.00127	0.00295	CbGbCtD
Omeprazole—CYP1A2—urine—prostate cancer	0.00115	0.0679	CbGeAlD
Omeprazole—ABCB1—Doxorubicin—prostate cancer	0.0011	0.00255	CbGbCtD
Omeprazole—CYP2C9—urine—prostate cancer	0.00109	0.0645	CbGeAlD
Omeprazole—ATP4A—epithelium—prostate cancer	0.00106	0.0628	CbGeAlD
Omeprazole—CYP2D6—Doxorubicin—prostate cancer	0.00103	0.0024	CbGbCtD
Omeprazole—ATP4A—renal system—prostate cancer	0.000986	0.0583	CbGeAlD
Omeprazole—CYP3A4—Etoposide—prostate cancer	0.000964	0.00224	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—prostate cancer	0.000882	0.00205	CbGbCtD
Omeprazole—CYP3A4—urine—prostate cancer	0.000832	0.0492	CbGeAlD
Omeprazole—CYP2D6—urine—prostate cancer	0.000819	0.0484	CbGeAlD
Omeprazole—ABCC3—prostate gland—prostate cancer	0.000736	0.0435	CbGeAlD
Omeprazole—CYP3A4—Doxorubicin—prostate cancer	0.000657	0.00153	CbGbCtD
Omeprazole—ATP4A—testis—prostate cancer	0.000637	0.0377	CbGeAlD
Omeprazole—CYP1B1—prostate gland—prostate cancer	0.000576	0.034	CbGeAlD
Omeprazole—ABCC3—renal system—prostate cancer	0.000502	0.0296	CbGeAlD
Omeprazole—ABCG2—prostate gland—prostate cancer	0.000429	0.0253	CbGeAlD
Omeprazole—CYP11A1—testis—prostate cancer	0.000418	0.0247	CbGeAlD
Omeprazole—CYP1B1—renal system—prostate cancer	0.000393	0.0232	CbGeAlD
Omeprazole—ABCG2—seminal vesicle—prostate cancer	0.000363	0.0214	CbGeAlD
Omeprazole—Lansoprazole—CYP2C18—prostate cancer	0.000361	0.144	CrCbGaD
Omeprazole—ABCC3—testis—prostate cancer	0.000324	0.0192	CbGeAlD
Omeprazole—CYP11A1—lymph node—prostate cancer	0.000303	0.0179	CbGeAlD
Omeprazole—CYP2C8—renal system—prostate cancer	0.000301	0.0178	CbGeAlD
Omeprazole—Esomeprazole—CYP2C19—prostate cancer	0.0003	0.12	CrCbGaD
Omeprazole—CYP1A1—epithelium—prostate cancer	0.000299	0.0177	CbGeAlD
Omeprazole—Lansoprazole—CYP1B1—prostate cancer	0.000298	0.119	CrCbGaD
Omeprazole—ABCG2—urethra—prostate cancer	0.000287	0.017	CbGeAlD
Omeprazole—CYP1A2—renal system—prostate cancer	0.000281	0.0166	CbGeAlD
Omeprazole—CYP1A1—renal system—prostate cancer	0.000278	0.0164	CbGeAlD
Omeprazole—CYP1A1—urethra—prostate cancer	0.000273	0.0161	CbGeAlD
Omeprazole—CYP1B1—testis—prostate cancer	0.000254	0.015	CbGeAlD
Omeprazole—ABCC3—lymph node—prostate cancer	0.000235	0.0139	CbGeAlD
Omeprazole—ABCG2—bone marrow—prostate cancer	0.000221	0.0131	CbGeAlD
Omeprazole—Pantoprazole—CYP2C19—prostate cancer	0.000217	0.0867	CrCbGaD
Omeprazole—Rabeprazole—CYP2C19—prostate cancer	0.000217	0.0867	CrCbGaD
Omeprazole—Rabeprazole—CYP1A1—prostate cancer	0.000216	0.0864	CrCbGaD
Omeprazole—ABCB1—prostate gland—prostate cancer	0.000211	0.0125	CbGeAlD
Omeprazole—CYP3A4—renal system—prostate cancer	0.000204	0.012	CbGeAlD
Omeprazole—CYP2D6—renal system—prostate cancer	0.0002	0.0118	CbGeAlD
Omeprazole—CYP2C8—testis—prostate cancer	0.000194	0.0115	CbGeAlD
Omeprazole—Esomeprazole—CYP3A4—prostate cancer	0.000191	0.0763	CrCbGaD
Omeprazole—ABCG2—testis—prostate cancer	0.000189	0.0112	CbGeAlD
Omeprazole—CYP1B1—lymph node—prostate cancer	0.000184	0.0109	CbGeAlD
Omeprazole—ABCB1—seminal vesicle—prostate cancer	0.000179	0.0106	CbGeAlD
Omeprazole—Lansoprazole—CYP2C19—prostate cancer	0.000162	0.0647	CrCbGaD
Omeprazole—Lansoprazole—CYP1A1—prostate cancer	0.000161	0.0644	CrCbGaD
Omeprazole—ABCB1—epithelium—prostate cancer	0.000155	0.00918	CbGeAlD
Omeprazole—ABCB1—renal system—prostate cancer	0.000144	0.00852	CbGeAlD
Omeprazole—ABCB1—urethra—prostate cancer	0.000142	0.00837	CbGeAlD
Omeprazole—Pantoprazole—CYP3A4—prostate cancer	0.000138	0.0551	CrCbGaD
Omeprazole—Rabeprazole—CYP3A4—prostate cancer	0.000138	0.0551	CrCbGaD
Omeprazole—ABCG2—lymph node—prostate cancer	0.000137	0.00809	CbGeAlD
Omeprazole—CYP1A1—lymph node—prostate cancer	0.00013	0.00768	CbGeAlD
Omeprazole—CYP2D6—testis—prostate cancer	0.00013	0.00765	CbGeAlD
Omeprazole—ABCB1—bone marrow—prostate cancer	0.000109	0.00644	CbGeAlD
Omeprazole—Lansoprazole—CYP3A4—prostate cancer	0.000103	0.0411	CrCbGaD
Omeprazole—ABCB1—testis—prostate cancer	9.32e-05	0.0055	CbGeAlD
Omeprazole—ABCB1—lymph node—prostate cancer	6.75e-05	0.00399	CbGeAlD
Omeprazole—Visual impairment—Epirubicin—prostate cancer	1.94e-05	0.000151	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—prostate cancer	1.94e-05	0.000151	CcSEcCtD
Omeprazole—Hypertension—Prednisone—prostate cancer	1.94e-05	0.00015	CcSEcCtD
Omeprazole—Rash—Mitoxantrone—prostate cancer	1.94e-05	0.00015	CcSEcCtD
Omeprazole—Dermatitis—Mitoxantrone—prostate cancer	1.93e-05	0.00015	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.93e-05	0.00015	CcSEcCtD
Omeprazole—Headache—Mitoxantrone—prostate cancer	1.92e-05	0.000149	CcSEcCtD
Omeprazole—Insomnia—Docetaxel—prostate cancer	1.92e-05	0.000149	CcSEcCtD
Omeprazole—Myalgia—Prednisone—prostate cancer	1.91e-05	0.000148	CcSEcCtD
Omeprazole—Arthralgia—Prednisone—prostate cancer	1.91e-05	0.000148	CcSEcCtD
Omeprazole—Paraesthesia—Docetaxel—prostate cancer	1.91e-05	0.000148	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—prostate cancer	1.9e-05	0.000148	CcSEcCtD
Omeprazole—Anxiety—Prednisone—prostate cancer	1.9e-05	0.000148	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—prostate cancer	1.9e-05	0.000147	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.9e-05	0.000147	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—prostate cancer	1.89e-05	0.000147	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—prostate cancer	1.89e-05	0.000147	CcSEcCtD
Omeprazole—Discomfort—Prednisone—prostate cancer	1.89e-05	0.000146	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—prostate cancer	1.88e-05	0.000146	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—prostate cancer	1.88e-05	0.000146	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—prostate cancer	1.88e-05	0.000146	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.87e-05	0.000145	CcSEcCtD
Omeprazole—Flushing—Epirubicin—prostate cancer	1.87e-05	0.000145	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—prostate cancer	1.87e-05	0.000145	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—prostate cancer	1.87e-05	0.000145	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—prostate cancer	1.86e-05	0.000145	CcSEcCtD
Omeprazole—Insomnia—Capecitabine—prostate cancer	1.86e-05	0.000144	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—prostate cancer	1.85e-05	0.000144	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—prostate cancer	1.85e-05	0.000144	CcSEcCtD
Omeprazole—Paraesthesia—Capecitabine—prostate cancer	1.84e-05	0.000143	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—prostate cancer	1.84e-05	0.000143	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—prostate cancer	1.84e-05	0.000143	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—prostate cancer	1.84e-05	0.000143	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Asthenia—Etoposide—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Dyspnoea—Capecitabine—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Anaphylactic shock—Prednisone—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—prostate cancer	1.83e-05	0.000142	CcSEcCtD
Omeprazole—Nausea—Mitoxantrone—prostate cancer	1.82e-05	0.000142	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—prostate cancer	1.82e-05	0.000141	CcSEcCtD
Omeprazole—Infection—Prednisone—prostate cancer	1.82e-05	0.000141	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—prostate cancer	1.82e-05	0.000141	CcSEcCtD
Omeprazole—Pain—Docetaxel—prostate cancer	1.81e-05	0.000141	CcSEcCtD
Omeprazole—Constipation—Docetaxel—prostate cancer	1.81e-05	0.000141	CcSEcCtD
Omeprazole—Dyspepsia—Capecitabine—prostate cancer	1.81e-05	0.00014	CcSEcCtD
Omeprazole—Chills—Epirubicin—prostate cancer	1.81e-05	0.00014	CcSEcCtD
Omeprazole—Pruritus—Etoposide—prostate cancer	1.81e-05	0.00014	CcSEcCtD
Omeprazole—Shock—Prednisone—prostate cancer	1.8e-05	0.00014	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—prostate cancer	1.8e-05	0.00014	CcSEcCtD
Omeprazole—Nervous system disorder—Prednisone—prostate cancer	1.79e-05	0.000139	CcSEcCtD
Omeprazole—Tachycardia—Prednisone—prostate cancer	1.79e-05	0.000139	CcSEcCtD
Omeprazole—Decreased appetite—Capecitabine—prostate cancer	1.79e-05	0.000139	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—prostate cancer	1.78e-05	0.000138	CcSEcCtD
Omeprazole—Skin disorder—Prednisone—prostate cancer	1.78e-05	0.000138	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Capecitabine—prostate cancer	1.77e-05	0.000138	CcSEcCtD
Omeprazole—Fatigue—Capecitabine—prostate cancer	1.77e-05	0.000138	CcSEcCtD
Omeprazole—Hyperhidrosis—Prednisone—prostate cancer	1.77e-05	0.000137	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—prostate cancer	1.77e-05	0.000137	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—prostate cancer	1.76e-05	0.000137	CcSEcCtD
Omeprazole—Pain—Capecitabine—prostate cancer	1.76e-05	0.000136	CcSEcCtD
Omeprazole—Constipation—Capecitabine—prostate cancer	1.76e-05	0.000136	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—prostate cancer	1.75e-05	0.000136	CcSEcCtD
Omeprazole—Feeling abnormal—Docetaxel—prostate cancer	1.75e-05	0.000136	CcSEcCtD
Omeprazole—Diarrhoea—Etoposide—prostate cancer	1.75e-05	0.000136	CcSEcCtD
Omeprazole—Anorexia—Prednisone—prostate cancer	1.74e-05	0.000135	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—prostate cancer	1.74e-05	0.000135	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—prostate cancer	1.74e-05	0.000135	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—prostate cancer	1.74e-05	0.000135	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—prostate cancer	1.73e-05	0.000134	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—prostate cancer	1.73e-05	0.000134	CcSEcCtD
Omeprazole—Tension—Epirubicin—prostate cancer	1.72e-05	0.000134	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—prostate cancer	1.72e-05	0.000133	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—prostate cancer	1.7e-05	0.000132	CcSEcCtD
Omeprazole—Back pain—Epirubicin—prostate cancer	1.7e-05	0.000132	CcSEcCtD
Omeprazole—Feeling abnormal—Capecitabine—prostate cancer	1.69e-05	0.000131	CcSEcCtD
Omeprazole—Dizziness—Etoposide—prostate cancer	1.69e-05	0.000131	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—prostate cancer	1.69e-05	0.000131	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—prostate cancer	1.68e-05	0.000131	CcSEcCtD
Omeprazole—Gastrointestinal pain—Capecitabine—prostate cancer	1.68e-05	0.00013	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—prostate cancer	1.68e-05	0.00013	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—prostate cancer	1.68e-05	0.00013	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—prostate cancer	1.68e-05	0.00013	CcSEcCtD
Omeprazole—Chills—Doxorubicin—prostate cancer	1.67e-05	0.00013	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Prednisone—prostate cancer	1.67e-05	0.000129	CcSEcCtD
Omeprazole—Insomnia—Prednisone—prostate cancer	1.66e-05	0.000129	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—prostate cancer	1.65e-05	0.000128	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—prostate cancer	1.65e-05	0.000128	CcSEcCtD
Omeprazole—Paraesthesia—Prednisone—prostate cancer	1.64e-05	0.000128	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—prostate cancer	1.63e-05	0.000127	CcSEcCtD
Omeprazole—Urticaria—Capecitabine—prostate cancer	1.63e-05	0.000127	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—prostate cancer	1.63e-05	0.000126	CcSEcCtD
Omeprazole—Abdominal pain—Capecitabine—prostate cancer	1.62e-05	0.000126	CcSEcCtD
Omeprazole—Body temperature increased—Capecitabine—prostate cancer	1.62e-05	0.000126	CcSEcCtD
Omeprazole—Vomiting—Etoposide—prostate cancer	1.62e-05	0.000126	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—prostate cancer	1.62e-05	0.000126	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—prostate cancer	1.62e-05	0.000126	CcSEcCtD
Omeprazole—Agitation—Epirubicin—prostate cancer	1.61e-05	0.000125	CcSEcCtD
Omeprazole—Dyspepsia—Prednisone—prostate cancer	1.61e-05	0.000125	CcSEcCtD
Omeprazole—Rash—Etoposide—prostate cancer	1.61e-05	0.000125	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—prostate cancer	1.61e-05	0.000125	CcSEcCtD
Omeprazole—Headache—Etoposide—prostate cancer	1.6e-05	0.000124	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—prostate cancer	1.6e-05	0.000124	CcSEcCtD
Omeprazole—Tension—Doxorubicin—prostate cancer	1.59e-05	0.000124	CcSEcCtD
Omeprazole—Decreased appetite—Prednisone—prostate cancer	1.59e-05	0.000124	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—prostate cancer	1.59e-05	0.000123	CcSEcCtD
Omeprazole—Malaise—Epirubicin—prostate cancer	1.58e-05	0.000123	CcSEcCtD
Omeprazole—Fatigue—Prednisone—prostate cancer	1.58e-05	0.000123	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—prostate cancer	1.58e-05	0.000122	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—prostate cancer	1.58e-05	0.000122	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—prostate cancer	1.57e-05	0.000122	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—prostate cancer	1.57e-05	0.000122	CcSEcCtD
Omeprazole—Constipation—Prednisone—prostate cancer	1.57e-05	0.000122	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—prostate cancer	1.56e-05	0.000121	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—prostate cancer	1.56e-05	0.000121	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—prostate cancer	1.55e-05	0.00012	CcSEcCtD
Omeprazole—Cough—Epirubicin—prostate cancer	1.53e-05	0.000119	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—prostate cancer	1.53e-05	0.000119	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—prostate cancer	1.52e-05	0.000118	CcSEcCtD
Omeprazole—Nausea—Etoposide—prostate cancer	1.52e-05	0.000118	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—prostate cancer	1.51e-05	0.000118	CcSEcCtD
Omeprazole—Hypersensitivity—Capecitabine—prostate cancer	1.51e-05	0.000118	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisone—prostate cancer	1.51e-05	0.000117	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—prostate cancer	1.51e-05	0.000117	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—prostate cancer	1.5e-05	0.000117	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—prostate cancer	1.5e-05	0.000116	CcSEcCtD
Omeprazole—Gastrointestinal pain—Prednisone—prostate cancer	1.5e-05	0.000116	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—prostate cancer	1.49e-05	0.000116	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—prostate cancer	1.49e-05	0.000116	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—prostate cancer	1.49e-05	0.000116	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—prostate cancer	1.49e-05	0.000116	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—prostate cancer	1.49e-05	0.000116	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.48e-05	0.000115	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—prostate cancer	1.48e-05	0.000115	CcSEcCtD
Omeprazole—Asthenia—Capecitabine—prostate cancer	1.47e-05	0.000114	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—prostate cancer	1.46e-05	0.000114	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—prostate cancer	1.46e-05	0.000113	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—prostate cancer	1.46e-05	0.000113	CcSEcCtD
Omeprazole—Urticaria—Prednisone—prostate cancer	1.45e-05	0.000113	CcSEcCtD
Omeprazole—Pruritus—Capecitabine—prostate cancer	1.45e-05	0.000113	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—prostate cancer	1.45e-05	0.000113	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—prostate cancer	1.45e-05	0.000113	CcSEcCtD
Omeprazole—Abdominal pain—Prednisone—prostate cancer	1.45e-05	0.000112	CcSEcCtD
Omeprazole—Body temperature increased—Prednisone—prostate cancer	1.45e-05	0.000112	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—prostate cancer	1.44e-05	0.000112	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—prostate cancer	1.43e-05	0.000111	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—prostate cancer	1.43e-05	0.000111	CcSEcCtD
Omeprazole—Infection—Epirubicin—prostate cancer	1.42e-05	0.00011	CcSEcCtD
Omeprazole—Cough—Doxorubicin—prostate cancer	1.42e-05	0.00011	CcSEcCtD
Omeprazole—Shock—Epirubicin—prostate cancer	1.41e-05	0.000109	CcSEcCtD
Omeprazole—Diarrhoea—Capecitabine—prostate cancer	1.41e-05	0.000109	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—prostate cancer	1.4e-05	0.000109	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—prostate cancer	1.4e-05	0.000109	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—prostate cancer	1.4e-05	0.000109	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—prostate cancer	1.4e-05	0.000109	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—prostate cancer	1.4e-05	0.000108	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—prostate cancer	1.39e-05	0.000108	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—prostate cancer	1.38e-05	0.000107	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—prostate cancer	1.38e-05	0.000107	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—prostate cancer	1.38e-05	0.000107	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—prostate cancer	1.38e-05	0.000107	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—prostate cancer	1.38e-05	0.000107	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.37e-05	0.000107	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—prostate cancer	1.37e-05	0.000106	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—prostate cancer	1.36e-05	0.000106	CcSEcCtD
Omeprazole—Dizziness—Capecitabine—prostate cancer	1.36e-05	0.000106	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—prostate cancer	1.35e-05	0.000105	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—prostate cancer	1.35e-05	0.000105	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisone—prostate cancer	1.35e-05	0.000105	CcSEcCtD
Omeprazole—Rash—Docetaxel—prostate cancer	1.34e-05	0.000104	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—prostate cancer	1.34e-05	0.000104	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—prostate cancer	1.34e-05	0.000104	CcSEcCtD
Omeprazole—Headache—Docetaxel—prostate cancer	1.33e-05	0.000103	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—prostate cancer	1.32e-05	0.000103	CcSEcCtD
Omeprazole—Infection—Doxorubicin—prostate cancer	1.32e-05	0.000102	CcSEcCtD
Omeprazole—Asthenia—Prednisone—prostate cancer	1.31e-05	0.000102	CcSEcCtD
Omeprazole—Vomiting—Capecitabine—prostate cancer	1.31e-05	0.000101	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.3e-05	0.000101	CcSEcCtD
Omeprazole—Shock—Doxorubicin—prostate cancer	1.3e-05	0.000101	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—prostate cancer	1.3e-05	0.000101	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—prostate cancer	1.3e-05	0.000101	CcSEcCtD
Omeprazole—Rash—Capecitabine—prostate cancer	1.3e-05	0.000101	CcSEcCtD
Omeprazole—Pruritus—Prednisone—prostate cancer	1.29e-05	0.000101	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—prostate cancer	1.29e-05	0.000101	CcSEcCtD
Omeprazole—Dermatitis—Capecitabine—prostate cancer	1.29e-05	0.000101	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—prostate cancer	1.29e-05	0.0001	CcSEcCtD
Omeprazole—Headache—Capecitabine—prostate cancer	1.29e-05	0.0001	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—prostate cancer	1.29e-05	9.99e-05	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—prostate cancer	1.29e-05	9.98e-05	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—prostate cancer	1.28e-05	9.94e-05	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—prostate cancer	1.28e-05	9.91e-05	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—prostate cancer	1.27e-05	9.88e-05	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—prostate cancer	1.26e-05	9.8e-05	CcSEcCtD
Omeprazole—Nausea—Docetaxel—prostate cancer	1.26e-05	9.79e-05	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—prostate cancer	1.26e-05	9.79e-05	CcSEcCtD
Omeprazole—Diarrhoea—Prednisone—prostate cancer	1.25e-05	9.72e-05	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—prostate cancer	1.24e-05	9.66e-05	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—prostate cancer	1.24e-05	9.6e-05	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—prostate cancer	1.23e-05	9.58e-05	CcSEcCtD
Omeprazole—Pain—Epirubicin—prostate cancer	1.22e-05	9.51e-05	CcSEcCtD
Omeprazole—Constipation—Epirubicin—prostate cancer	1.22e-05	9.51e-05	CcSEcCtD
Omeprazole—Nausea—Capecitabine—prostate cancer	1.22e-05	9.48e-05	CcSEcCtD
Omeprazole—Dizziness—Prednisone—prostate cancer	1.21e-05	9.4e-05	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.21e-05	9.37e-05	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—prostate cancer	1.2e-05	9.3e-05	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—prostate cancer	1.19e-05	9.24e-05	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—prostate cancer	1.18e-05	9.17e-05	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—prostate cancer	1.18e-05	9.16e-05	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—prostate cancer	1.18e-05	9.14e-05	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—prostate cancer	1.17e-05	9.09e-05	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—prostate cancer	1.17e-05	9.05e-05	CcSEcCtD
Omeprazole—Vomiting—Prednisone—prostate cancer	1.16e-05	9.04e-05	CcSEcCtD
Omeprazole—Rash—Prednisone—prostate cancer	1.15e-05	8.96e-05	CcSEcCtD
Omeprazole—Dermatitis—Prednisone—prostate cancer	1.15e-05	8.95e-05	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—prostate cancer	1.15e-05	8.94e-05	CcSEcCtD
Omeprazole—Headache—Prednisone—prostate cancer	1.15e-05	8.9e-05	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.14e-05	8.88e-05	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—prostate cancer	1.14e-05	8.87e-05	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—prostate cancer	1.14e-05	8.83e-05	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—prostate cancer	1.13e-05	8.8e-05	CcSEcCtD
Omeprazole—Pain—Doxorubicin—prostate cancer	1.13e-05	8.8e-05	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—prostate cancer	1.13e-05	8.79e-05	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—prostate cancer	1.13e-05	8.79e-05	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—prostate cancer	1.09e-05	8.48e-05	CcSEcCtD
Omeprazole—Nausea—Prednisone—prostate cancer	1.09e-05	8.44e-05	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.08e-05	8.41e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—prostate cancer	1.05e-05	8.19e-05	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—prostate cancer	1.05e-05	8.17e-05	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—prostate cancer	1.05e-05	8.13e-05	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—prostate cancer	1.05e-05	8.13e-05	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—prostate cancer	1.03e-05	7.98e-05	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—prostate cancer	1.01e-05	7.86e-05	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—prostate cancer	9.79e-06	7.61e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—prostate cancer	9.76e-06	7.58e-05	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—prostate cancer	9.5e-06	7.38e-05	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—prostate cancer	9.47e-06	7.35e-05	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—prostate cancer	9.37e-06	7.28e-05	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—prostate cancer	9.1e-06	7.07e-05	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—prostate cancer	9.06e-06	7.04e-05	CcSEcCtD
Omeprazole—Rash—Epirubicin—prostate cancer	9.03e-06	7.01e-05	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—prostate cancer	9.02e-06	7e-05	CcSEcCtD
Omeprazole—Headache—Epirubicin—prostate cancer	8.97e-06	6.96e-05	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—prostate cancer	8.76e-06	6.8e-05	CcSEcCtD
Omeprazole—Nausea—Epirubicin—prostate cancer	8.5e-06	6.6e-05	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—prostate cancer	8.42e-06	6.54e-05	CcSEcCtD
Omeprazole—Rash—Doxorubicin—prostate cancer	8.35e-06	6.49e-05	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—prostate cancer	8.34e-06	6.48e-05	CcSEcCtD
Omeprazole—Headache—Doxorubicin—prostate cancer	8.3e-06	6.44e-05	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—prostate cancer	7.87e-06	6.11e-05	CcSEcCtD
Omeprazole—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.31e-06	1.42e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP17A1—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.3e-06	1.41e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.3e-06	1.41e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ERCC2—prostate cancer	1.29e-06	1.41e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP19A1—prostate cancer	1.29e-06	1.41e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—P4HB—prostate cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.28e-06	1.4e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RXRA—prostate cancer	1.28e-06	1.39e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—prostate cancer	1.28e-06	1.39e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—prostate cancer	1.27e-06	1.38e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—prostate cancer	1.26e-06	1.37e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—prostate cancer	1.26e-06	1.37e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GGT1—prostate cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—prostate cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RXRA—prostate cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GGT1—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOA2—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—LPL—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NCOA1—prostate cancer	1.24e-06	1.34e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—COMT—prostate cancer	1.23e-06	1.34e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—prostate cancer	1.23e-06	1.33e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NCOA1—prostate cancer	1.23e-06	1.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.22e-06	1.33e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.22e-06	1.32e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—prostate cancer	1.22e-06	1.32e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.21e-06	1.31e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ITPR1—prostate cancer	1.21e-06	1.31e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MED12—prostate cancer	1.2e-06	1.31e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—COMT—prostate cancer	1.2e-06	1.31e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—prostate cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARA—prostate cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GNG5—prostate cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ERCC2—prostate cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ITPR1—prostate cancer	1.18e-06	1.28e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RXRA—prostate cancer	1.18e-06	1.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RXRA—prostate cancer	1.17e-06	1.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.16e-06	1.26e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—prostate cancer	1.16e-06	1.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA3—prostate cancer	1.15e-06	1.25e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—prostate cancer	1.15e-06	1.25e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NQO1—prostate cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—prostate cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—COMT—prostate cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TH—prostate cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—prostate cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—prostate cancer	1.13e-06	1.22e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—COMT—prostate cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAV1—prostate cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—prostate cancer	1.12e-06	1.21e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.12e-06	1.21e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—prostate cancer	1.12e-06	1.21e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—prostate cancer	1.11e-06	1.21e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.11e-06	1.21e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ITPR1—prostate cancer	1.11e-06	1.21e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—LPL—prostate cancer	1.11e-06	1.2e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ITPR1—prostate cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—prostate cancer	1.1e-06	1.19e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—prostate cancer	1.1e-06	1.19e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.1e-06	1.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HPGDS—prostate cancer	1.1e-06	1.19e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARA—prostate cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.09e-06	1.18e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—LPL—prostate cancer	1.08e-06	1.17e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.07e-06	1.16e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.07e-06	1.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ACHE—prostate cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—prostate cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GGT1—prostate cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ERCC2—prostate cancer	1.06e-06	1.15e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOA1—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—prostate cancer	1.04e-06	1.13e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—prostate cancer	1.04e-06	1.13e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—prostate cancer	1.04e-06	1.13e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ERCC2—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAV1—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PRKACB—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—LPL—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—LPL—prostate cancer	1.01e-06	1.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.01e-06	1.09e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—prostate cancer	1e-06	1.09e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RXRA—prostate cancer	9.96e-07	1.08e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—prostate cancer	9.95e-07	1.08e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—prostate cancer	9.93e-07	1.08e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.83e-07	1.07e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—prostate cancer	9.82e-07	1.07e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARA—prostate cancer	9.76e-07	1.06e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ERCC2—prostate cancer	9.74e-07	1.06e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.73e-07	1.06e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—prostate cancer	9.71e-07	1.06e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.69e-07	1.05e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—INS—prostate cancer	9.67e-07	1.05e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ERCC2—prostate cancer	9.65e-07	1.05e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—COMT—prostate cancer	9.59e-07	1.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA2—prostate cancer	9.59e-07	1.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—prostate cancer	9.55e-07	1.04e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—prostate cancer	9.53e-07	1.04e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARA—prostate cancer	9.53e-07	1.04e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CREBBP—prostate cancer	9.47e-07	1.03e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ITPR1—prostate cancer	9.4e-07	1.02e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—prostate cancer	9.37e-07	1.02e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.24e-07	1e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAV1—prostate cancer	9.18e-07	9.98e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—prostate cancer	9.15e-07	9.95e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.15e-07	9.94e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—prostate cancer	9.08e-07	9.86e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—prostate cancer	8.98e-07	9.76e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARA—prostate cancer	8.98e-07	9.76e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAV1—prostate cancer	8.96e-07	9.74e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.94e-07	9.71e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARA—prostate cancer	8.9e-07	9.68e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—prostate cancer	8.88e-07	9.65e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—INS—prostate cancer	8.87e-07	9.64e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NQO1—prostate cancer	8.84e-07	9.6e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—prostate cancer	8.77e-07	9.54e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.77e-07	9.53e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TH—prostate cancer	8.71e-07	9.46e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CREBBP—prostate cancer	8.69e-07	9.44e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—LPL—prostate cancer	8.61e-07	9.36e-06	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—prostate cancer	8.59e-07	9.34e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—prostate cancer	8.48e-07	9.22e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.47e-07	9.21e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAV1—prostate cancer	8.44e-07	9.18e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAV1—prostate cancer	8.37e-07	9.1e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.36e-07	9.09e-06	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—prostate cancer	8.35e-07	9.08e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—prostate cancer	8.32e-07	9.04e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ERCC2—prostate cancer	8.25e-07	8.97e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.24e-07	8.95e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GGT1—prostate cancer	8.2e-07	8.92e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—prostate cancer	8.16e-07	8.87e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA1—prostate cancer	8.08e-07	8.78e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8e-07	8.69e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.96e-07	8.66e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—INS—prostate cancer	7.92e-07	8.6e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—prostate cancer	7.83e-07	8.51e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—prostate cancer	7.78e-07	8.45e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—prostate cancer	7.76e-07	8.43e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—prostate cancer	7.75e-07	8.43e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CREBBP—prostate cancer	7.75e-07	8.43e-06	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—prostate cancer	7.75e-07	8.42e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—INS—prostate cancer	7.73e-07	8.4e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—prostate cancer	7.69e-07	8.36e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RXRA—prostate cancer	7.69e-07	8.35e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.62e-07	8.29e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARA—prostate cancer	7.61e-07	8.27e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CREBBP—prostate cancer	7.57e-07	8.22e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—COMT—prostate cancer	7.4e-07	8.05e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—prostate cancer	7.37e-07	8.01e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.35e-07	7.99e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—INS—prostate cancer	7.28e-07	7.91e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ITPR1—prostate cancer	7.25e-07	7.88e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—INS—prostate cancer	7.22e-07	7.84e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.18e-07	7.8e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—prostate cancer	7.18e-07	7.8e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAV1—prostate cancer	7.15e-07	7.77e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CREBBP—prostate cancer	7.13e-07	7.75e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—prostate cancer	7.11e-07	7.73e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CREBBP—prostate cancer	7.07e-07	7.68e-06	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—prostate cancer	7.05e-07	7.66e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—prostate cancer	6.94e-07	7.54e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—prostate cancer	6.85e-07	7.45e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.83e-07	7.43e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—prostate cancer	6.78e-07	7.36e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—prostate cancer	6.77e-07	7.36e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—prostate cancer	6.77e-07	7.35e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—prostate cancer	6.76e-07	7.35e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.7e-07	7.29e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LPL—prostate cancer	6.65e-07	7.22e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—prostate cancer	6.52e-07	7.08e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—prostate cancer	6.45e-07	7.01e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.42e-07	6.98e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.41e-07	6.96e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—prostate cancer	6.38e-07	6.94e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ERCC2—prostate cancer	6.37e-07	6.92e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—prostate cancer	6.35e-07	6.9e-06	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—prostate cancer	6.33e-07	6.88e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—prostate cancer	6.33e-07	6.88e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—prostate cancer	6.25e-07	6.8e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—prostate cancer	6.2e-07	6.74e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—prostate cancer	6.2e-07	6.74e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—INS—prostate cancer	6.17e-07	6.7e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CREBBP—prostate cancer	6.04e-07	6.57e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—prostate cancer	5.99e-07	6.51e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—prostate cancer	5.92e-07	6.43e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.89e-07	6.41e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARA—prostate cancer	5.87e-07	6.38e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.84e-07	6.35e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—prostate cancer	5.84e-07	6.35e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—prostate cancer	5.79e-07	6.29e-06	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—prostate cancer	5.76e-07	6.26e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—prostate cancer	5.73e-07	6.23e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—prostate cancer	5.54e-07	6.02e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAV1—prostate cancer	5.52e-07	6e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—prostate cancer	5.41e-07	5.88e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—prostate cancer	5.4e-07	5.87e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—prostate cancer	5.28e-07	5.74e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—prostate cancer	5.15e-07	5.6e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—prostate cancer	5.09e-07	5.54e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—prostate cancer	5.05e-07	5.49e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.03e-07	5.47e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.99e-07	5.43e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—prostate cancer	4.95e-07	5.38e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—prostate cancer	4.86e-07	5.28e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—prostate cancer	4.81e-07	5.23e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—prostate cancer	4.77e-07	5.19e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—INS—prostate cancer	4.76e-07	5.17e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CREBBP—prostate cancer	4.66e-07	5.07e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.42e-07	4.8e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.38e-07	4.76e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—prostate cancer	4.31e-07	4.69e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—prostate cancer	4.17e-07	4.54e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—prostate cancer	4.11e-07	4.47e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.91e-07	4.25e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—prostate cancer	3.9e-07	4.24e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.85e-07	4.19e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—prostate cancer	3.82e-07	4.15e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—prostate cancer	3.81e-07	4.14e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.59e-07	3.9e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—prostate cancer	3.57e-07	3.89e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.56e-07	3.87e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—prostate cancer	3.33e-07	3.62e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—prostate cancer	3.19e-07	3.47e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—prostate cancer	3.18e-07	3.45e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—prostate cancer	3.11e-07	3.39e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—prostate cancer	3.04e-07	3.31e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—prostate cancer	2.93e-07	3.19e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—prostate cancer	2.91e-07	3.16e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—prostate cancer	2.49e-07	2.7e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.35e-07	2.55e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—prostate cancer	1.92e-07	2.09e-06	CbGpPWpGaD
